Media

The Biotechnology Industry Organization (BIO) today announced that it will showcase a series of unique sessions at this year’s Livestock Biotech Summit...
Sessions to focus on the FDA Breakthrough Therapy Designation Process, IPO Market, and BioCentury’s Back to School issue

Press Releases

Feb 11 2003
WASHINGTON, D.C. (February 11, 2003)—The Biotechnology Industry Organization (BIO) today announced an array of industry experts that will discuss the future of...
Feb 5 2003
Washington, D.C. (February 5, 2003) - Michael Werner, vice president for bioethics at the Biotechnology Industry Organization (BIO), today issued the following...
Feb 5 2003
Washington, D.C. (February 5, 2003) - Michael Werner, vice president for bioethics at the Biotechnology Industry Organization (BIO), today issued the following...
Feb 4 2003
WASHINGTON, D.C. (February 4, 2003) - The Biotechnology Industry Organization (BIO) will host its fifth annual CEO & Investor Conference February 25-27 at...
Jan 29 2003
Washington, D.C. (January 29, 2003) − Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement in...
Jan 29 2003
WASHINGTON, D.C. (January 29, 2003) – Richard F. Pops, CEO of Alkermes, Inc., and vice-chair of healthcare for the Biotechnology Industry Organization...
Jan 28 2003
WASHINGTON, D.C. (January 28, 2003) — Media registration is now open for the Biotechnology Industry Organization’s (BIO) CEO & Investor Conference 2003,...
Jan 28 2003
WASHINGTON, D.C. (January 28, 2003) – Food and Drug Administration (FDA) Commissioner Mark B. McClellan, M.D., Ph.D., will speak at the Biotechnology Industry...
Jan 24 2003
Washington, D.C. (January 24, 2003) – Carl B. Feldbaum, President of the Biotechnology Industry Organization (BIO) today announced the establishment of a new...


Biotechnology News

September 18, 2014

WEST CHESTER, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and Left Atrial Appendage...

September 18, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea's Lymphoseek lymphatic mapping imaging agent received Orphan Drug Designation from FDA for use in sentinel lymph node detection in...

September 18, 2014

MONTIGNY LE BRETONNEUX, France--(BUSINESS WIRE)--Bertin Technologies launches Precellys ® Evolution, its brand new biological sample homogenizer in the Precellys range.

September 18, 2014

PARIS--(BUSINESS WIRE)--Regulatory News : Cegedim, a global technology and services company in the healthcare field, announces that its 2014 Half-Year Financial Report has...

September 18, 2014

BERLIN--(BUSINESS WIRE)--EBS Technologies reports that a clinical study published in Neurology® validates electrical brain stimulation technology designed to expand the...